GlycanAge was founded on a promise that “health care” should start with us caring about our health before we encounter a particular problem. Disease starts on a molecular level decades before we are currently addressing it, while the majority of modern disease is preventable and the earliest molecular signal is biological ageing. GlycanAge allows you to measure & influence your longevity by looking at an entirely new part of biology. Glycan biomarkers uniquely encapsulate genetic, epigenetic and environmental factors driving longevity for every human.
Nikolina Lauc, CEO of Glycanage, believes that we will need to focus on multiomics to improve aging clocks. Multiomics describes a data collection process in which multiple domains of diagnostics are collected simultaneously – such as the genome, glycome, proteome, etc. Glycanage stumbled across a correlation between glycosylation phenotypes and age, and they have begun to investigate how that ties into diet and exercise. They created an aging clock – a correlation between biomarkers and chronological age – using glycosylation data. As they investigated the relationships further, they realized they need to structure their data with other aging clocks to produce something that can lead to useful therapies. Nikolina is willing to contribute glycosylation data to such an effort.